Nigerian Doctor Drives Trust and Evidence in Women’s Health Tech

Dr. Ayomide Owodunni is pushing for a stronger, more credible approach in the fast-growing FemTech sector. She established an advisory system that assists startups in developing evidence-based products which build trust with users and investors in women’s health products.
Her career started in clinical practice where she saw many women struggle with health issues that were often misunderstood or ignored. Solid scientific foundations and effective communication methods would enable developed tools and solutions to achieve successful outcomes in their intended purpose.

She dedicated her professional work to FemTech which focuses on developing technological solutions that improve women’s health outcomes. Dr Ayomide observed that numerous startups possessed innovative ideas yet they failed to demonstrate valid proof of their product efficacy. This created difficulties in establishing trust with female users while maintaining investor confidence.

Today, she works as a FemTech Credibility Advisor. She assists startups in developing scientifically based products which deliver accurate information and satisfy regulatory requirements. She wants products to be clear, reliable, and safe for the women who use them.

Your training includes information which extends to the month of October in the year 2023. Dr. Ayomide assists founders by helping them to identify all potential credibility hazards which exist at the beginning of their business development process. She assists teams in product evaluation by reviewing their claims and developing their product development strategies while also helping them to prepare for both regulatory assessments and investor evaluations. Her work aims to stop all upcoming issues from developing into future problems.

She provides various services including a women’s health science newsletter and credibility audits which verify all claims and materials and her continuous advisory work and product evaluations before major product releases or fundraising activities. The services enable founders to establish product trustworthiness through organized procedures which start from their initial development phase.

She has established her presence in the larger FemTech community through her research work which deals with inclusive design and clinical credibility. Dr. Ayomide demonstrates that when founders establish their business through credibility their company development will result in better healthcare for women and improved investment choices for their investors.

The FemTech industry will witness an increase in its overall standards because the industry demands both evidence and transparency in all its operations. The approach of Dr Ayomide demonstrates how clinical knowledge needs to combine with strategic advice to enable startups to develop trustworthy products which will serve women across the globe.